329 related articles for article (PubMed ID: 28870581)
1. Pharmacological treatments for fatigue in patients with multiple sclerosis: A systematic review and meta-analysis.
Yang TT; Wang L; Deng XY; Yu G
J Neurol Sci; 2017 Sep; 380():256-261. PubMed ID: 28870581
[TBL] [Abstract][Full Text] [Related]
2. Treatments for fatigue in multiple sclerosis: a rapid and systematic review.
Brañas P; Jordan R; Fry-Smith A; Burls A; Hyde C
Health Technol Assess; 2000; 4(27):1-61. PubMed ID: 11074395
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological treatments for fatigue associated with palliative care.
Mücke M; ; Cuhls H; Peuckmann-Post V; Minton O; Stone P; Radbruch L
Cochrane Database Syst Rev; 2015 May; 2015(5):CD006788. PubMed ID: 26026155
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological treatments for fatigue associated with palliative care.
Peuckmann V; Elsner F; Krumm N; Trottenberg P; Radbruch L
Cochrane Database Syst Rev; 2010 Nov; (11):CD006788. PubMed ID: 21069692
[TBL] [Abstract][Full Text] [Related]
5. Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo.
Krupp LB; Coyle PK; Doscher C; Miller A; Cross AH; Jandorf L; Halper J; Johnson B; Morgante L; Grimson R
Neurology; 1995 Nov; 45(11):1956-61. PubMed ID: 7501140
[TBL] [Abstract][Full Text] [Related]
6. Treating fatigue.
Lapierre Y; Hum S
Int MS J; 2007 Jun; 14(2):64-71. PubMed ID: 17686346
[TBL] [Abstract][Full Text] [Related]
7. Treating fatigue in patients with MS: one step forward, one step back.
Schwid SR; Murray TJ
Neurology; 2005 Apr; 64(7):1111-2. PubMed ID: 15824329
[No Abstract] [Full Text] [Related]
8. The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis.
Geisler MW; Sliwinski M; Coyle PK; Masur DM; Doscher C; Krupp LB
Arch Neurol; 1996 Feb; 53(2):185-8. PubMed ID: 8639070
[TBL] [Abstract][Full Text] [Related]
9. Treatment of fatigue with methylphenidate, modafinil and amantadine in multiple sclerosis (TRIUMPHANT-MS): Study design for a pragmatic, randomized, double-blind, crossover clinical trial.
Nourbakhsh B; Revirajan N; Waubant E
Contemp Clin Trials; 2018 Jan; 64():67-76. PubMed ID: 29113955
[TBL] [Abstract][Full Text] [Related]
10. Amantadine for fatigue in multiple sclerosis.
Taus C; Giuliani G; Pucci E; D'Amico R; Solari A
Cochrane Database Syst Rev; 2003; (2):CD002818. PubMed ID: 12804439
[TBL] [Abstract][Full Text] [Related]
11. Amantadine for fatigue in multiple sclerosis.
Pucci E; Branãs P; D'Amico R; Giuliani G; Solari A; Taus C
Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD002818. PubMed ID: 17253480
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the effects of amantadin, modafinil and acetyl-L-carnitine on fatigue in multiple sclerosis--result of a pilot randomized, blind study.
Ledinek AH; Sajko MC; Rot U
Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S86-9. PubMed ID: 24321164
[TBL] [Abstract][Full Text] [Related]
13. [Pathophysiology and treatment of fatigue in multiple sclerosis].
Boërio D; Lefaucheur JP; Hogrel JY; Créange A
Rev Neurol (Paris); 2006 Mar; 162(3):311-20. PubMed ID: 16585886
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial.
Nourbakhsh B; Revirajan N; Morris B; Cordano C; Creasman J; Manguinao M; Krysko K; Rutatangwa A; Auvray C; Aljarallah S; Jin C; Mowry E; McCulloch C; Waubant E
Lancet Neurol; 2021 Jan; 20(1):38-48. PubMed ID: 33242419
[TBL] [Abstract][Full Text] [Related]
15. ['Fatigue' in multiple sclerosis].
Zimmermann C; Hohlfeld R
Nervenarzt; 1999 Jun; 70(6):566-74. PubMed ID: 10412704
[TBL] [Abstract][Full Text] [Related]
16. Carnitine for fatigue in multiple sclerosis.
Tejani AM; Wasdell M; Spiwak R; Rowell G; Nathwani S
Cochrane Database Syst Rev; 2010 Feb; (2):CD007280. PubMed ID: 20166093
[TBL] [Abstract][Full Text] [Related]
17. Management of fatigue in patients with multiple sclerosis.
Zifko UA
Drugs; 2004; 64(12):1295-304. PubMed ID: 15200345
[TBL] [Abstract][Full Text] [Related]
18. Carnitine for fatigue in multiple sclerosis.
Tejani AM; Wasdell M; Spiwak R; Rowell G; Nathwani S
Cochrane Database Syst Rev; 2012 May; 2012(5):CD007280. PubMed ID: 22592719
[TBL] [Abstract][Full Text] [Related]
19. Does amantadine have favourable effects on fatigue in Persian patients suffering from multiple sclerosis?
Ashtari F; Fatehi F; Shaygannejad V; Chitsaz A
Neurol Neurochir Pol; 2009; 43(5):428-32. PubMed ID: 20054744
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial.
Tomassini V; Pozzilli C; Onesti E; Pasqualetti P; Marinelli F; Pisani A; Fieschi C
J Neurol Sci; 2004 Mar; 218(1-2):103-8. PubMed ID: 14759641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
